Study summary · research use only
Design and implementation of a high yield production system for recombinant expression of peptides
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This study describes development of a flexible recombinant expression and purification system for cell-penetrating peptides in Escherichia coli. The abstract explains target peptides were produced in insoluble form by fusion to a hexahistidine-tagged ketosteroid isomerase, then separated by a thrombin cleavage reaction. The system was tested on the anticancer peptides p53pAnt and PNC27, comprising regions of the p53 protein fused to the cell-penetrating peptide Penetratin. It reports high yields of purified fused peptides in both cases, though thrombin cleavage succeeded only for p53pAnt, achieving over 30 mg of pure p53pAnt peptide per g of dry cell mass. The authors propose the system for producing other peptides.
Abstract
Making peptide pharmaceuticals involves challenging processes where many barriers, which include production and manufacture, need to be overcome. A non common but interesting research area is related to peptides with intracellular targets, which opens up new possibilities, allowing the modulation of processes occurring within the cell or interference with signaling pathways. However, if the bioactive sequence requires fusion to a carrier peptide to allow access into the cell, the resulting peptide could be such a length that traditional production could be difficult. The goal of the present study was the development of a flexible recombinant expression and purification system for peptides, as a contribution to the discovery and development of these potentially new drugs. In this work, a high throughput recombinant expression and purification system for production of cell penetrating peptides in Escherichia coli has been designed and implemented. The system designed produces target peptides in an insoluble form by fusion to a hexahistidine tagged ketosteroid isomerase which is then separated by a highly efficient thrombin cleavage reaction procedure. The expression system was tested on the anticancer peptides p53pAnt and PNC27. These peptides comprise the C-terminal region and the N-terminal region of the protein p53, respectively, fused by its carboxyl terminal extreme to the cell penetrating peptide Penetratin. High yields of purified recombinant fused peptides were obtained in both cases; nevertheless, thrombin cleavage reaction was successful only for p53pAnt peptide release. The features of the system, together with the procedure developed, allow achievement of high production yields of over 30 mg of highly pure p53pAnt peptide per g of dry cell mass. It is proposed that the system could be used for production of other peptides at a similar yield. This study provides a system suitable for recombinant production of peptides for scientific research, including biological assays.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.